Home › Trial NCT00563316
Effect of Panitumumab on the Pharmacokinetics of Irinotecan
- Trial IDNCT00563316
- StatusCompleted
- PhasePhase 1
- Study typeInterventional
- SponsorAmgen
- Enrollment28
- Start date2008-03
- ConditionsMetastatic Colorectal Cancer
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.